BridgeMD
New treatment option for Benign Paroxysmal Positional Vertigo
Official title Personalized Treatment of Refractory BPPV
ClinicalTrials.gov ID: NCT06725966
What this study is testing
- What it's testing
- Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- A. Diagnosed with BPPVp according to the Barany Society criteria:
- Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.
- Episodes lasting less than 1 minute.
- Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component...
- Symptoms not explained by any other cause. AND
You likely can't join if
- Cognitive impairment that prevents understanding of their condition and the required procedures.
- Pathological conditions that hinder the execution of the maneuvers.
- BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
- Low educational level, which may impede understanding of the procedures and informed consent.
See the full eligibility criteria
- A. Diagnosed with BPPVp according to the Barany Society criteria:
- Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position.
- Episodes lasting less than 1 minute.
- Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right).
- Symptoms not explained by any other cause. AND
- B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts.
- Cognitive impairment that prevents understanding of their condition and the required procedures.
- Pathological conditions that hinder the execution of the maneuvers.
- BPPV involving canals other than the posterior canal or bilateral posterior canal involvement.
- Low educational level, which may impede understanding of the procedures and informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago de Compostela, A Coruña, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago de Compostela, A Coruña, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.